Burkholderia cenocepacia virulence microevolution in the CF lung: Variations on a theme.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

6 citing papers in PubMed.

1. Synergistic Interactions amongMicrobiology spectrum · 2023
   Article
2. The Isolation and Characterization of a Broad Host Range Bcep22-like Podovirus JC1.Viruses · 2022
   Article
3. Gasdermin D restricts Burkholderia cenocepacia infection in vitro and in vivo.Scientific reports · 2021
   Article
4. Comparative analysis of the Burkholderia cenocepacia K56-2 essential genome reveals cell envelope functions that are uniquely required for survival in species of the genus Burkholderia.Microbial genomics · 2017
   Article
5. Virulence traits associated withAntimicrobial resistance and infection control · 2017
   Article
6. Genome Reduction for Niche Association inFrontiers in cellular and infection microbiology · 2017
   Article

Corrections and comments

• Comment on
  Variation of Burkholderia cenocepacia virulence potential during cystic fibrosis chronic lung infection.2017

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as